The new Center for Metabolic-Immunological Diseases and Therapeutic Technologies Saxony (MITS) has opened at Dresden University Hospital in the eastern German state of Saxony. According to the Dresden University of Technology, specialists in internal medicine, endocrinology, immunology, surgery, cell biology as well as transplant medicine have laboratories, offices, and rooms for research, teaching, and therapy in the modern new building. The investment of 35.1 million euros was financed by the federal and state governments, including initial equipment and large-scale pieces of equipment. According to the statement, this will allow the metabolism in the organism to be fully recorded, cells to be isolated, and cell functions to be observed.
At MITS, science and medicine will "develop methods for the diagnosis and prevention of metabolic diseases such as diabetes, which will then be rapidly translated into innovative therapeutic approaches," said MITS spokesman Stefan Bornstein. For example, he said, research is ongoing into the bioreactor, which in the future will be transplanted under the skin onto the peritoneum, similar to the pacemaker, and will produce insulin as needed and deliver it to the body. "It's about a new, innovative understanding of how the regulation of the immune system works," Bornstein said.
According to hospital data, more than eight million people in Germany suffer from diabetes, and their numbers are increasing by 1,000 sufferers every day - by almost 40 percent in the past 20 years. Among the elderly population, about one in five people is affected. The consequences are visible obesity and an increased risk of heart attack, blindness, and circulatory problems.
Notice: No person, organization and/or company shall disseminate or broadcast the above article on Xinhua Silk Road website without prior permission by Xinhua Silk Road.
A single purchase
